Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model
Authors:
Open Access
- 30 September 2024
- Vol. 112 (23) , 3877-3896.e8
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- BrightFocus Foundation
- Rainwater Charitable Foundation
- Foundation for the National Institutes of Health
- Cure Alzheimer's Fund
- National Institute on Aging
- American Foundation for Aging Research
- Jumpstart
- JPB Foundation
This publication has 128 references indexed in Scilit:
- Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)Alzheimer's & Dementia, 2021
- APOE and metabolic dysfunction in Alzheimer's disease2020
- Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathwayCellular and Molecular Life Sciences, 2017
- Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion modelsBrain, Behavior, and Immunity, 2017
- Sex differences in the association between AD biomarkers and cognitive declineBrain Imaging and Behavior, 2016
- R47H Variant ofTREM2Associated With Alzheimer Disease in a Large Late-Onset FamilyJAMA Neurology, 2015
- Sex modifies the APOE‐related risk of developing Alzheimer diseaseAnnals of Neurology, 2014
- APOE genotype alters glial activation and loss of synaptic markers in miceGlia, 2012
- Sex Differences in the Clinical Manifestations of Alzheimer Disease PathologyArchives of General Psychiatry, 2005
- Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease BrainNeurobiology of Disease, 2000